Users Discontinuing Anti-Obesity Jabs Put On Pounds Far More Rapidly Than Dieters

Image of medical syringe and weighing machine
Weight management involves long-term strategies.

New research indicates that individuals who come off popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end traditional lifestyle plans.

Findings released in a major medical journal demonstrates that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"People purchasing such treatments need to be informed of the risk of fast weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to starting weight in about one and a half years.

Weighing Treatments

The analysis, which looked at 37 of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.

The team emphasize that individuals who shed pounds through dieting usually experience a slower creep back—approximately 0.1 kg a month—once they finish.

The Reason for the Quick Regain

Nutrition scientists believe the way of the drugs is key to understanding the heightened regain.

These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."

An Ongoing Condition?

Medical guidelines advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Many experts contend that, due to the significant potential of weight regain, the therapy might need to be ongoing.

This perspective is echoed by drug manufacturers, who state that the findings "emphasize the chronic nature of excess weight," akin to managing diseases like diabetes.

User Testimonies

Individuals who have stopped the jabs describe a intense return of appetite.

"I experienced something flipping and you become starving," recalled one woman.

The struggle is compounded if patients have not developed lasting dietary or behavioural modifications during treatment.

Significant Adoption

Survey data show that a significant number of adults in the UK have used these injections in the past year, with demand continuing to grow.

  • Use is greater among females than males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the drugs through private healthcare rather than public health services.

Finally, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone fix and lasting health benefits relies on integrated lifestyle changes.

Kimberly Taylor
Kimberly Taylor

A seasoned real estate expert specializing in Italian luxury properties, with over a decade of experience in the Rimini market.